9 March 2026
Credit: Getty Images/D-KeineBy Ellie Crabbe, PA
Gender-affirming hormone treatment for 16 and 17-year-olds has been paused after an NHS review found evidence does not support its continued use.
The treatment has been available on the NHS for 16 and 17-year-olds with a diagnosis of gender dysphoria who meet certain criteria, but new referrals have been paused from Monday.